SCHEMBL1719840

SCHEMBL1719840

C1=NC=NC1.[MgH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL251268 0.96
SCHEMBL2315815 0.93
SCHEMBL27598619 0.93
SCHEMBL3854312 0.93
SCHEMBL3286387 0.93
SCHEMBL5534423 0.90
Hydrochloric Acid SCHEMBL11581409 0.90
Hydrochloric Acid SCHEMBL4024833 0.90
Bromide SCHEMBL5862208 0.90
SCHEMBL10650470 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113387889-B Preparation method of porous imidazole metal compound nano-powder 湖南文理学院 2023-05-09 CN disclosed
CN-113387889-A Novel porous imidazole metal compound nano powder and preparation method thereof 湖南文理学院 2021-09-14 CN disclosed
EP-2173735-B1 IMIDAZOLE DERIVATIVES AS CCR2 RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2012-01-11 EP disclosed
US-7935707-B2 Imidazole derivatives HOFFMAN-LA ROCHE INC. (US) 2011-05-03 US disclosed
EP-2173735-A1 IMIDAZOLE DERIVATIVES AS CCR2 RECEPTOR ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-04-14 EP disclosed
US-20090012063-A1 Novel imidazole derivatives HOFFMANN-LA ROCHE, INC. 2009-01-08 US disclosed
WO-2009003861-A1 IMIDAZOLE DERIVATIVES AS CCR2 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-01-08 WO disclosed
WO-2005047281-A1 NOVEL HERBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2005-05-26 WO disclosed